Article Information
History
- March 16, 2017.
Article Versions
- Version 1 (March 15, 2017 - 11:45).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- †External Sciences, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal 43183, Sweden
- ‡Quantitative Biology, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal 43183, Sweden
- ‖Drug Safety and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal 43183, Sweden
- €Swetox, Karolinska Institutet, Unit of Toxicology Sciences, Södertälje, Sweden
- ↵Corresponding Author Hongming Chen Hongming.Chen{at}astrazeneca.com